Call: 212-877-7475 Text: 917-693-8269 Email: Zusindental@gmail.com
Dental Blog · August 30, 2026

MAD Titration: How Jaw Position Is Adjusted Step by Step (and When to Stop)

Titration isn't a single adjustment — it's a staged process with a conservative starting position, small defined increments, and a firm ceiling, because efficacy plateaus well before maximum protrusion while side effects keep climbing. Here's how it actually works...

MAD Titration: How Jaw Position Is Adjusted Step by Step (and When to Stop)

By Dr. Boris Zusin · Published August 30, 2026 · Updated September 5, 2026

Titration is the process of gradually adjusting a mandibular advancement device (MAD) to find the jaw position that controls your sleep apnea without causing unnecessary discomfort. It's a stepwise process guided by both your symptoms and objective sleep testing — not a single adjustment made at your first fitting. The core principle guiding modern titration is worth stating up front: the goal is the minimal effective protrusion, not the maximum tolerable one, because efficacy plateaus well before most patients reach their comfort ceiling while dentoskeletal and jaw-joint side effects keep climbing the further the jaw is advanced.

Starting Position and Maximum Protrusion

At the time your appliance is fabricated, your maximum comfortable jaw protrusion is measured with a bite-registration tool (often called a George Gauge) — and the reference point used for that measurement matters more than it might seem. Guidance from the German Society of Dental Sleep Medicine recommends measuring from active maximum retrusion (pulling the jaw as far back as comfortably possible) rather than your relaxed, habitual bite, since it's a more reproducible starting reference. From there, the Society recommends beginning treatment at roughly 50% of that maximum — a position that should feel comfortable and free of pain or muscle tension from night one. Published protocols vary somewhat wider than that single number, with starting positions reported anywhere from 50–75% of maximum (and some more conservative protocols starting as low as 0–25%), but there's a clear trend in more recent guidance toward the lower, more conservative end specifically to reduce side effects; many trial protocols simply start around 60% and adjust from there. It's also worth keeping the vertical opening of the appliance as low as your lab and bite allow — excessive vertical opening reduces how much actual forward protrusion you get for a given amount of appliance bulk, can reduce how consistently the appliance gets worn, and may make the airway itself more prone to collapse.

Many patients wear the appliance nightly for a period of acclimatization — getting used to sleeping with it in place, comfortably and pain-free through the whole night — before advancement begins in earnest.

How Advancement Happens: The Increment Schedule

From that starting point, the jaw is advanced further in small, defined steps until symptoms improve, side effects become limiting, or the maximum comfortable protrusion is reached. Two approaches show up most often in the published protocols:

  • Fixed millimeter steps — commonly up to about 1 mm at a time (finer 0.3–0.5 mm steps if jaw-joint discomfort develops), spaced roughly 2–3 weeks apart to give the jaw joints and chewing muscles time to adapt before the next adjustment. Some clinic protocols instead use fixed check-in intervals — for example at 4, 8, and 12 weeks — advancing by about 15% of maximum protrusion at each visit if symptoms aren't yet controlled.
  • Percentage steps — advancing a set percentage of maximum protrusion per visit, and stepping back if side effects become unacceptable. In practice, most patients land somewhere around 70% of their maximum protrusion by the time titration is complete.

If discomfort develops — particularly one-sided jaw-joint pain, which does happen since the two sides of the jaw don't always tolerate advancement identically — the usual approach is to back off the advancement on the affected side specifically until symptoms resolve, then resume with smaller increments from there. It's a normal, expected outcome for the final titrated position to end up slightly asymmetric between the two sides rather than perfectly even. Most jaw-joint soreness during this phase settles down within the first few months, though a specific minority of patients keep having symptoms much longer — see our breakdown of who's at higher risk for persistent TMJ pain and what helps if that's you.

Respect the Efficacy Plateau

This is the part of titration that's easy to get backwards: more advancement doesn't keep buying you more benefit. A systematic review and meta-regression across multiple studies found that advancing beyond roughly 50% of maximum protrusion did not produce a statistically significant further improvement in treatment success (how much AHI actually came down) — the relationship between advancement amount and success is close to flat past that point, which is the core argument for favoring lower advancement specifically to limit side effects rather than chasing a theoretical ceiling. A separate dose-response analysis found the same pattern from a different angle: reductions in AHI and in a more granular measure of respiratory effort increase with more protrusion, but the benefit curve flattens out past roughly 6.5 mm of advancement (about 70% of maximum), meaning additional advancement past that point adds mechanical load without adding much real benefit.

Meanwhile, the side-effect side of that trade-off keeps climbing the further you go. A finite element (computer biomechanical modeling) study found periodontal ligament and cancellous (spongy) bone stress was lowest around 40% of maximum protrusion, while advancing to 70% or more produced stresses exceeding thresholds associated with bone resorption — concentrated particularly around the lower second molars — along with the highest modeled risk of root resorption. On the dental side, a separate clinical cohort found that advancing to 95% or more of maximum protrusion produced meaningfully more upper-incisor tipping (3.43° more, on average) than staying below that threshold, with both greater advancement and longer treatment duration predicting progressively more change over time — which is exactly why gradual titration that avoids pushing all the way to maximum protrusion matters, not just for comfort but for your teeth and jaw joints long-term. (We cover this side-effect picture, and what does and doesn't help prevent it, in more detail in our piece on morning occlusal guides and MAD-related bite changes.)

Individualizing by Facial Structure

How much advancement it actually takes to get a meaningful response isn't the same for everyone — your underlying facial (craniofacial) structure shifts the picture substantially. Research on this looked specifically at vertical facial pattern: patients with a low mandibular-plane angle (a flatter, more horizontal facial growth pattern) often cross the threshold for a 50% reduction in AHI at as little as 20% of their maximum protrusion, while patients with a high-angle (steeper, more vertical) facial pattern typically need roughly 50% advancement to get there — and tend to show a ceiling effect, gaining comparatively little added benefit, and potentially more unfavorable vertical side effects, beyond about 70–80% of maximum. The practical takeaway is the same principle as above applied individually: the target is the least protrusion that controls your particular case, which is exactly why titration is a personalized, gradual process rather than a fixed formula applied identically to everyone.

Confirming the Final Position

Once titration seems complete, an objective sleep test — either an in-lab study or a home sleep apnea test — with the appliance in place is the step that actually confirms it's working, rather than relying on how you feel alone. That confirmation step matters: symptom relief by itself can be misleading in a meaningful share of patients, some of whom feel better but still have residual oxygen desaturation on testing, and others whose oximetry looks normal but whose symptoms haven't actually resolved. Newer approaches are starting to move this confirmation step earlier in the process rather than only at the end: remotely controlled mandibular positioning performed during an in-lab sleep study or a drug-induced sleep endoscopy can help identify your effective protrusive position directly and objectively, rather than arriving at it purely through trial and error across multiple visits. Other emerging tools — take-home sensors that track jaw position and wearing time overnight, and acoustic pharyngometry, a technique that measures airway dimensions to help guide appliance design — are aimed at the same goal: identifying the effective target position with less guesswork and less unnecessary advancement along the way. Since excessive protrusion driven by subjective titration alone is a common, avoidable cause of both dental change and jaw-joint intolerance, objective confirmation is what actually lets you settle at the lowest effective position rather than an arbitrarily higher one.

Titration Reduces Risk, but Doesn't Eliminate It

It's worth being clear-eyed that even well-executed, conservative titration doesn't fully prevent dental and bite changes from developing over time. Posterior open bite and incisor tipping can still appear despite following every precaution described above, and a recent sensor-based study found that patients with higher objectively measured nightly wearing time — the very thing that makes a MAD effective in the first place — showed correspondingly greater long-term tooth movement. That's not an argument against consistent use; it's a reminder that titration, appliance design, and monitoring work together to manage risk, not eliminate it entirely, which is exactly why regular dental follow-up and up-front honest expectations remain part of the plan alongside careful titration itself.

Endpoints: When to Stop Advancing

Advancement stops when one of several endpoints is reached:

  • Symptom resolution — snoring and daytime sleepiness meaningfully improve or resolve.
  • Objective respiratory control — on a follow-up sleep test, this generally means an AHI under 5 events per hour (normalization) or at least a 50% reduction from baseline (an effective, if not fully normalized, result).
  • Maximum comfortable protrusion — jaw joint or chewing-muscle discomfort sets a hard ceiling regardless of whether the respiratory numbers would benefit from more advancement.
  • A plateau in benefit — as detailed above, the relationship between how far the jaw is advanced and how much it helps isn't linear, and benefit tends to level off well before maximum protrusion, so pushing further past that point usually adds more mechanical stress and discomfort than benefit.

When to Reconsider or Discontinue Therapy Altogether

Separate from simply stopping advancement at the right position, there are reasons to reconsider the appliance itself over time:

  • Persistent or intolerable side effects — excess salivation, dry mouth, tooth or jaw pain, and a temporary bite change noticeable first thing in the morning are common and usually manageable, but a minority of patients discontinue therapy because of them. Guideline authors are clear that therapy shouldn't simply be stopped without an alternative in place — most side effects can be managed by an experienced dentist rather than requiring the appliance to be abandoned. Some clinicians add a morning occlusal guide to help the bite re-seat after that temporary morning shift, though it's worth knowing what the evidence actually shows about how well that works — and it's worth understanding the broader distinction between which MAD side effects are temporary and which are permanent before you're deciding whether something is worth raising at your next visit.
  • Efficacy that fades over time — long-term data show a gradual decline in how well a MAD controls apnea events year over year, alongside slow dental and bite changes. Recurrent symptoms, a significant weight change, or new health conditions relevant to sleep apnea are all reasons to be re-evaluated rather than assuming the original fitting still applies.
  • Treatment-emergent central sleep apnea — a small subset of patients develop a different type of breathing event (central, rather than obstructive) once the airway obstruction is treated, which is part of why periodic reassessment matters even after a successful initial fitting.
  • Nonadherence — roughly one in five patients stops using their appliance within the first year, and that dropout risk continues to climb the longer someone is followed. That's the strongest argument for staying engaged with regular dental follow-up rather than quietly discontinuing on your own if the appliance starts to feel like a hassle.

The bottom line: titration starts around 50–70% of maximum jaw protrusion, advances in small steps guided by your symptoms, and stops once your breathing events are controlled, benefit plateaus, or comfort sets a limit — then gets confirmed with an actual sleep test rather than a guess. After that, periodic follow-up (not a one-time fitting) is what keeps the appliance working well for the long run — see our full breakdown of what that ongoing follow-up schedule actually looks like.

Sources

← The Straw DemoPredictors of MAD Success →

Have a Dental Question of Your Own?

Reach out and we'll help you find the right next step.

Schedule Your Visit Call 212-877-7475
Call 212-877-7475 Directions Schedule Visit